![Lee Golden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lee Golden
Hoofd Techniek/Wetenschap/O&O bij
PTC THERAPEUTICS, INC.
Vermogen: 6 M $ op 31-05-2026
Profiel
Dr. Lee S.
Golden, MD, is an Independent Director at Cadrenal Therapeutics, Inc. and a Chief Medical Officer & Executive Vice President at PTC Therapeutics, Inc. He is on the Board of Directors at Cadrenal Therapeutics, Inc. Dr. Golden was previously employed as a Chief Medical Officer by Espero Pharmaceuticals, Inc., a Chief Medical Officer by Gemphire Therapeutics, Inc., a Head-Pulmonary by Mesoblast Ltd., a Head-Cardiovascular & Blood Disorders by Eisai, Inc., a Senior Director-US Medical by Actelion Pharmaceuticals US, Inc., and a Medical Director by Pfizer Inc. He also served on the board at Coagulation Sciences LLC.
He received his undergraduate degree from the University of Michigan and a doctorate degree from New York University School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-04-2026 | 79.964 ( 0,1% ) | 6 M $ | 31-05-2026 | |
| 02-12-2025 | 1.667 ( 0,06% ) | 8 268 $ | 31-05-2026 |
Actieve functies van Lee Golden
| Bedrijven | Functie | Begin |
|---|---|---|
| PTC THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
| CADRENAL THERAPEUTICS, INC. | Directeur/Bestuurslid | 24-11-2025 |
Eerdere bekende functies van Lee Golden
| Bedrijven | Functie | Einde |
|---|---|---|
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Hoofd Techniek/Wetenschap/O&O | 01-05-2020 |
| METAVIA INC. | Hoofd Techniek/Wetenschap/O&O | 18-09-2018 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 01-10-2016 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Corporate Officer/Principal | 01-07-2011 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Corporate Officer/Principal | 01-03-2008 |
Opleiding van Lee Golden
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
58
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coagulation Sciences LLC
 Coagulation Sciences LLC Medical/Nursing ServicesHealth Services Provides blood-testing solutions | Health Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Distribution Services |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
